Skip to main content

Table 1 Clinical characteristics of the study populations

From: Prognostic value of peripheral blood natural killer cells in colorectal cancer

Variables

Value

Age

59.5 ± 13.08

Gender

 Male/Female

258/189

Location

 Colon/Rectal

224/223

Histological grade

 High/Middle/Low

53/86/308

T stage

 T1/T2/ T3/ T4/ TX

7/52/102/251/35

N stage

 N0/N1/N2/N3

152/160/89/46

M stage

 M0/M1/MX

279/157/11

White blood cells

6.36 (5.14–8.10)

Hemoglobin

118.5 (102.2–130.1)

Platelet

271.3 (215.5–339.5)

Neutrophil

3.85 (2.93–5.23)

Lymphocyte

1.62 (1.27–2.03)

ALB

36.60 (33.90–39.30)

CEA

3.11 (1.21–17.71)

CA125

10.80 (7.10–25.15)

CA153

8.50 (4.95–12.95)

CA199

16.60 (8.15–39.55)

T lymphocyte

65.10 (59.70–71.25)

B lymphocyte

12.70 (9.40–16.20)

NK

15.60 (11.45–20.20)

CRP

3.31 (1.34–11.29)

hsCRP

0.83 (0.42–3.85)

NLR

2.29 (1.65–3.43)

PLR

165.42 (119.81–242.77)

CAR

0.09 (0.03–0.32)

  1. NK Natural killer, CEA Carcinoembryonic antigen, ALB Albumin, CRP C-reactive protein, hsCRP High sensitivity C-reactive protein, NLR Neutrophil-lymphocyte ratio, PLR Platelet lymphocytes ratio, CAR CRP/ALB ratio